21:23:59 EDT Mon 20 May 2024
Enter Symbol
or Name
USA
CA



Aurora Cannabis Inc
Symbol ACB
Shares Issued 951,849,208
Close 2018-09-18 C$ 11.02
Market Cap C$ 10,489,378,272
Recent Sedar Documents

Aurora reaches supply deal with four more provinces

2018-09-18 13:17 ET - News Release

Mr. Terry Booth reports

AURORA CANNABIS POSITIONED COAST TO COAST WITH PROVINCIAL SUPPLY ARRANGEMENTS APPOINTS DARREN KARASIUK AS EXECUTIVE VICE PRESIDENT OF ADULT USAGE, GLOBAL

Aurora Cannabis Inc. and its wholly owned subsidiary MedReleaf have entered into additional supply arrangements with a number of provinces across Canada to supply a broad range of dried flower and higher margin products, such as prerolls, oils and capsules. In addition to supplying adult consumer use markets in British Columbia, Alberta, Ontario, Quebec and Nova Scotia, the company is pleased to advise of arrangements with the Yukon, Manitoba, Prince Edward Island, and Newfoundland and Labrador. The Aurora and MedReleaf brands are expected to have a strong presence across Canada, positioning the company well for rapid growth in the upcoming adult use market.

Appointment of Darren Karasiuk, executive vice-president of adult usage, global

The company also announces the appointment of Mr. Karasiuk as its new executive vice-president of adult usage, global. Mr. Karasiuk will be responsible for the execution of Aurora's commercial adult use strategy, which includes oversight of adult-use retail, marketing, sales, business intelligence and analytics, partnerships, and customer service.

Mr. Karasiuk joins Aurora through the acquisition of MedReleaf where he was senior vice-president and general manager, recreational, where he was responsible for MedReleaf's adult use cannabis business which included the development and introduction of the AltaVie and San Rafael '71 brands into the marketplace, as well as the stewardship of the partnership with the Woodstock Cannabis Company.

Mr. Karasiuk has deep experience in highly regulated industries, including private and public health care, pharma, tobacco, consumer packaged goods, and energy. Prior to joining MedReleaf, Mr. Karasiuk was vice-president, insights and advisory, at Deloitte, where he was a leader in the firm's cannabis practice, co-authoring the firm's seminal study, "Recreational Marijuana: Insights and Opportunities." Previously, Mr. Karasiuk was vice-president, strategy, corporate and public affairs, at Environics Research, where he conducted many of Canada's earliest engagements on the cannabis sector. He has also been the Canadian associate for the Marijuana Policy Group, a leading Denver-based economic and policy consulting firm which helped shape the regulated medical and recreational cannabis markets. Mr. Karasiuk holds an MA from Western University and an MBA from Kellogg-Schulich.

Management commentary

"We have now secured important supply arrangements from coast to coast, covering approximately 98 per cent of the Canadian population, reflecting the scale and quality of our operations," said Terry Booth, chief executive officer. "We will supply a large number of products to the adult use market, including dried flower and higher margin form factors, such as capsules, oils and prerolls. We are also exceptionally pleased that Darren has agreed to join our team and take on the leadership of Aurora's adult usage business. His expertise in market development within heavily regulated environments, his track record in bringing adult usage brands to market, and his connections and credibility throughout the industry are invaluable assets for us. We welcome Darren and look forward to working closely with him as Aurora rises to new heights."

Mr. Karasiuk added: "Aurora is an exceptional company, innovating and executing at the most rapid pace in the industry. The strengths of both companies -- high-volume, low-cost cultivation capacity, product quality, brands and people -- position us well to grow rapidly in these new and exciting markets. I look forward to being part of the team."

Granting of stock options and restricted share units to officers

The company also announced today that it has granted an aggregate of 205,000 stock options and 55,000 restricted share units to officers of the company. The stock options are exercisable at a price of $8.54 per share for a period of five years from the date of grant. Both options and RSUs vest annually over 36 months.

About Aurora Cannabis Inc.

Headquartered in Edmonton, Alta., Canada, with financed capacity in excess of 500,000 kilograms per year and sales and operations in 18 countries across five continents, Aurora is one of the world's largest and leading cannabis companies. Aurora is vertically integrated and horizontally diversified across every key segment of the value chain, from facility engineering and design to cannabis breeding and genetics research, cannabis and hemp production, derivatives, high value-add product development, home cultivation, and wholesale and retail distribution.

We seek Safe Harbor.

© 2024 Canjex Publishing Ltd. All rights reserved.